1 week ago
2
Hikma Pharmaceuticals USA (OTCPK:HKMPF) plans to invest $1 billion through 2030 to boost its U.S. manufacturing and R&D.
Under its "America Leans on Hikma" initiative, investment aims to enhance the company's domestic capacity to provide a broad range of medicines for the U.S. healthcare system.
English (US) ·